Kalydeco 150 MG tablet 56S
Ended Awarded
- Contract number
- SPE2DB25FAZJW
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $18,489
Award facts
- Contract value 100% obligated
- $18,489.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $18,489 by the Defense Logistics Agency (DLA) for Kalydeco 150 mg tablets (56-count). This firm fixed-price delivery order, issued on August 1, 2025, with an ultimate completion date of August 4, 2025, represents a discrete fulfillment under DMS Pharmaceutical Group's larger indefinite delivery contract with DLA. The award carries no set-aside designation, demonstrating the company's competitive positioning in federal pharmaceutical procurement markets.
This delivery order is issued under DMS Pharmaceutical Group's significant single-award IDC with DLA valued at $499,999,999 and valid through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products supporting military health facility operations worldwide. The company has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The Kalydeco tablets, a cystic fibrosis treatment medication, will be delivered to the place of performance in Park Ridge, Illinois, supporting the DLA's mission to provide essential medications to military medical facilities.
Quick answers
Who was awarded contract SPE2DB25FAZJW?
SPE2DB25FAZJW was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FAZJW worth?
The government has obligated $18,489 on SPE2DB25FAZJW.
Is contract SPE2DB25FAZJW an order under another contract?
Yes. SPE2DB25FAZJW is a delivery order under SPE2DB24D9222, an indefinite delivery contract.
Was contract SPE2DB25FAZJW competed?
The extent of competition for SPE2DB25FAZJW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award